首页 > 最新文献

Interventional Cardiology Review最新文献

英文 中文
Incidence and Pathology of Aortic Regurgitation. 主动脉反流的发生率和病理。
IF 0.2 0 PHILOSOPHY Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.15420/icr.2024.37
Lucas Uchoa de Assis, Giulio M Mondellini, Mark Mp van den Dorpel, Jenna van Niekerk, Nicolas M Van Mieghem

Aortic regurgitation (AR) is the third most common valvular heart disease, with its prevalence and severity increasing with age. AR can arise from degenerative, congenital, inflammatory and infectious aetiologies, manifesting as primary AR with intrinsic leaflet disease, secondary AR due to aortopathy or annular dilatation, or a combination. Furthermore, AR can be acute, as observed in endocarditis and aortic dissection, or chronic, as seen in calcific aortic valve disease, connective tissue disorders, or bicuspid valve phenotypes. This review discusses the aetiopathology of these various AR manifestations (primary, secondary, acute and chronic AR), highlighting diagnostic challenges and implications for aortic valve replacement and transcatheter aortic valve implantation.

主动脉瓣反流(AR)是第三大最常见的瓣膜性心脏病,其患病率和严重程度随着年龄的增长而增加。AR可由退行性、先天性、炎症性和感染性病因引起,表现为原发性AR伴有内在小叶疾病,由于主动脉病变或血管环扩张而继发性AR,或两者兼而有之。此外,AR可以是急性的,如心内膜炎和主动脉夹层,也可以是慢性的,如钙化主动脉瓣疾病、结缔组织疾病或二尖瓣表型。本文讨论了各种AR表现(原发性、继发性、急性和慢性AR)的病因病理学,强调了诊断挑战和主动脉瓣置换术和经导管主动脉瓣植入术的意义。
{"title":"Incidence and Pathology of Aortic Regurgitation.","authors":"Lucas Uchoa de Assis, Giulio M Mondellini, Mark Mp van den Dorpel, Jenna van Niekerk, Nicolas M Van Mieghem","doi":"10.15420/icr.2024.37","DOIUrl":"10.15420/icr.2024.37","url":null,"abstract":"<p><p>Aortic regurgitation (AR) is the third most common valvular heart disease, with its prevalence and severity increasing with age. AR can arise from degenerative, congenital, inflammatory and infectious aetiologies, manifesting as primary AR with intrinsic leaflet disease, secondary AR due to aortopathy or annular dilatation, or a combination. Furthermore, AR can be acute, as observed in endocarditis and aortic dissection, or chronic, as seen in calcific aortic valve disease, connective tissue disorders, or bicuspid valve phenotypes. This review discusses the aetiopathology of these various AR manifestations (primary, secondary, acute and chronic AR), highlighting diagnostic challenges and implications for aortic valve replacement and transcatheter aortic valve implantation.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"20 ","pages":"e07"},"PeriodicalIF":0.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11934125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143711504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patent Foramen Ovale Closure: British Cardiovascular Intervention Society Position Statement. 卵圆孔未闭闭合:英国心血管介入学会立场声明。
IF 0.2 0 PHILOSOPHY Pub Date : 2025-02-19 eCollection Date: 2025-01-01 DOI: 10.15420/icr.2024.18
Mark Turner, Suneil K Aggarwal, Michael J Mullen, Iqbal Malik, Philip MacCarthy, David Northridge, Mark S Spence, Bushra Rana, David Hildick-Smith

The foramen ovale is a flap in the atrial septum that is open in the fetus to allow oxygenated blood returning from the placenta to pass to the systemic circulation. In early life, the primum septal flap should close, but in 25% of people the flap does not seal fully. Most patent foramen ovale (PFO) are small and open only following Valsalva. Resting right-to-left shunts are less common, occurring in 5% of individuals. This British Cardiovascular Intervention Society position statement describes the diagnosis, indications and procedure for PFO closure.

卵圆孔是胎儿心房间隔上的一个皮瓣,它在胎儿体内打开,允许含氧血液从胎盘返回到体循环。在生命早期,原间隔瓣应该闭合,但25%的人瓣不能完全闭合。大多数未闭卵圆孔(PFO)很小,仅在Valsalva后开放。静息从右到左分流不太常见,发生率为5%。这份英国心血管介入协会的立场声明描述了PFO关闭的诊断、适应症和程序。
{"title":"Patent Foramen Ovale Closure: British Cardiovascular Intervention Society Position Statement.","authors":"Mark Turner, Suneil K Aggarwal, Michael J Mullen, Iqbal Malik, Philip MacCarthy, David Northridge, Mark S Spence, Bushra Rana, David Hildick-Smith","doi":"10.15420/icr.2024.18","DOIUrl":"https://doi.org/10.15420/icr.2024.18","url":null,"abstract":"<p><p>The foramen ovale is a flap in the atrial septum that is open in the fetus to allow oxygenated blood returning from the placenta to pass to the systemic circulation. In early life, the primum septal flap should close, but in 25% of people the flap does not seal fully. Most patent foramen ovale (PFO) are small and open only following Valsalva. Resting right-to-left shunts are less common, occurring in 5% of individuals. This British Cardiovascular Intervention Society position statement describes the diagnosis, indications and procedure for PFO closure.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"20 ","pages":"e04"},"PeriodicalIF":0.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143626377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gadolinium-guided Transcatheter Aortic Valve Implantation in a Patient with Renal Impairment and a History of Severe Allergic Reaction to Iodinated Contrast Media. 钆引导下经导管主动脉瓣植入术治疗肾功能不全且对碘造影剂有严重过敏反应的患者。
IF 0.2 0 PHILOSOPHY Pub Date : 2025-02-18 eCollection Date: 2025-01-01 DOI: 10.15420/icr.2024.15
Bandar Alshehri, Hussein Alamri, Naif Alghasab, Jamal Ahmed, Fahad Alshehri, Sondos Samargandy, Abdulrahman M Almoghairi

Iodinated contrast media is integral to the evaluation for transcatheter aortic valve implantation; however, some patients may have contraindications to the use of iodinated contrast media. The study reports successful use of a gadolinium-based contrast agent in a patient with severe symptomatic aortic stenosis, contrast allergy and post-contrast acute kidney injury.

碘化造影剂是经导管主动脉瓣植入术评估中不可或缺的一部分;然而,有些患者可能有使用碘化造影剂的禁忌症。该研究报告称,一位患有严重症状性主动脉瓣狭窄、造影剂过敏和造影后急性肾损伤的患者成功使用了钆类造影剂。
{"title":"Gadolinium-guided Transcatheter Aortic Valve Implantation in a Patient with Renal Impairment and a History of Severe Allergic Reaction to Iodinated Contrast Media.","authors":"Bandar Alshehri, Hussein Alamri, Naif Alghasab, Jamal Ahmed, Fahad Alshehri, Sondos Samargandy, Abdulrahman M Almoghairi","doi":"10.15420/icr.2024.15","DOIUrl":"https://doi.org/10.15420/icr.2024.15","url":null,"abstract":"<p><p>Iodinated contrast media is integral to the evaluation for transcatheter aortic valve implantation; however, some patients may have contraindications to the use of iodinated contrast media. The study reports successful use of a gadolinium-based contrast agent in a patient with severe symptomatic aortic stenosis, contrast allergy and post-contrast acute kidney injury.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"20 ","pages":"e03"},"PeriodicalIF":0.2,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcified Coronary Artery Disease: Pathology, Prevalence, Predictors and Impact on Outcomes. 钙化冠状动脉疾病:病理学、患病率、预测因素和对结果的影响
IF 0.2 0 PHILOSOPHY Pub Date : 2025-02-14 eCollection Date: 2025-01-01 DOI: 10.15420/icr.2024.20
Angela McInerney, Seán O Hynes, Nieves Gonzalo

Calcified coronary artery disease is a common clinical finding and is visible angiographically in 25-30% of patients presenting for percutaneous coronary intervention. The presence of coronary calcium, even without coronary artery obstruction, confers an adverse clinical prognosis. Coronary calcium score on CT is additive in predicting risk of cardiovascular events beyond traditional scoring systems. Deposition of calcium in coronary arteries is initiated by the formation of an atherosclerotic plaque. Thereafter, multiple processes and pathways are involved, resulting in initial microcalcifications that coalesce into calcium sheets. Calcified nodules are thought to occur from rupture of these sheets. Calcified coronary stenoses requiring revascularisation result in greater target lesion failure and overall major adverse cardiovascular events than noncalcified lesions, regardless of the mode of revascularisation. Modifying calcium prior to stenting to optimise stent expansion is required and intracoronary imaging can greatly facilitate not only the detection of coronary calcium, but also the confirmation of adequate modification and stent optimisation. In this review, the authors examine the pathophysiology, prevalence, predictors and impact on outcomes of coronary calcium.

钙化冠状动脉疾病是一种常见的临床表现,在25-30%接受经皮冠状动脉介入治疗的患者中可见。冠状动脉钙的存在,即使没有冠状动脉阻塞,也会导致不良的临床预后。CT冠状动脉钙化评分在预测心血管事件风险方面比传统评分系统更具附加价值。冠状动脉中的钙沉积是由动脉粥样硬化斑块的形成引起的。此后,涉及多个过程和途径,导致最初的微钙化合并成钙片。钙化结节被认为是由这些薄片破裂引起的。与非钙化病变相比,需要血管重建的钙化冠状动脉狭窄导致更大的靶病变失败和总体主要心血管不良事件,无论血管重建模式如何。需要在支架置入前修改钙以优化支架扩张,冠状动脉内成像不仅可以极大地促进冠状动脉钙的检测,而且可以确认适当的修改和支架优化。在这篇综述中,作者研究了冠状动脉钙化的病理生理、患病率、预测因素及其对结果的影响。
{"title":"Calcified Coronary Artery Disease: Pathology, Prevalence, Predictors and Impact on Outcomes.","authors":"Angela McInerney, Seán O Hynes, Nieves Gonzalo","doi":"10.15420/icr.2024.20","DOIUrl":"https://doi.org/10.15420/icr.2024.20","url":null,"abstract":"<p><p>Calcified coronary artery disease is a common clinical finding and is visible angiographically in 25-30% of patients presenting for percutaneous coronary intervention. The presence of coronary calcium, even without coronary artery obstruction, confers an adverse clinical prognosis. Coronary calcium score on CT is additive in predicting risk of cardiovascular events beyond traditional scoring systems. Deposition of calcium in coronary arteries is initiated by the formation of an atherosclerotic plaque. Thereafter, multiple processes and pathways are involved, resulting in initial microcalcifications that coalesce into calcium sheets. Calcified nodules are thought to occur from rupture of these sheets. Calcified coronary stenoses requiring revascularisation result in greater target lesion failure and overall major adverse cardiovascular events than noncalcified lesions, regardless of the mode of revascularisation. Modifying calcium prior to stenting to optimise stent expansion is required and intracoronary imaging can greatly facilitate not only the detection of coronary calcium, but also the confirmation of adequate modification and stent optimisation. In this review, the authors examine the pathophysiology, prevalence, predictors and impact on outcomes of coronary calcium.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"20 ","pages":"e02"},"PeriodicalIF":0.2,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11865672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention Society. 英国经皮冠状动脉介入治疗:英国心血管介入协会的建议。
IF 0.2 0 PHILOSOPHY Pub Date : 2025-01-23 eCollection Date: 2025-01-01 DOI: 10.15420/icr.2024.43
Nick Curzen, Helen Routledge, Samuel McGrath, Mohamed Abouelasaad, Mamas Mamas, Tim Kinnaird, Rasha Al-Lamee, Peter O'Kane, Gerald Clesham, Dan McKenzie, James Nolan, Shrilla Banerjee, Clare Appleby, Adrian Banning, Douglas F Muir, James Spratt, Ellie Gudde, Sarah Carson, Suneil Aggarwal, John Irving, Vinoda Sharma, Ian Purcell, Azfar Zaman, David Hildick-Smith

Percutaneous techniques to treat obstructive coronary artery disease continue to evolve and the evidence base informing our practice is shared and summarised in international guidelines. In the UK, the British Cardiovascular Intervention Society represents and supports interventional cardiologists undertaking both coronary and structural interventions. Procedural data are collected in a national registry and these inform our understanding of UK practice and outcomes. These recommendations, pertaining to coronary intervention alone, are an update of those published in 2015 and describe the provision of percutaneous coronary intervention in the UK intended to provide optimal patient care.

治疗阻塞性冠状动脉疾病的经皮技术在不断发展,国际指南分享并总结了指导我们实践的证据基础。在英国,英国心血管介入协会代表并支持介入心脏病专家进行冠状动脉和结构性介入治疗。手术数据由国家登记处收集,这些数据有助于我们了解英国的实践和结果。这些建议仅涉及冠状动脉介入治疗,是对 2015 年发布的建议的更新,描述了英国经皮冠状动脉介入治疗的提供情况,旨在为患者提供最佳治疗。
{"title":"Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention Society.","authors":"Nick Curzen, Helen Routledge, Samuel McGrath, Mohamed Abouelasaad, Mamas Mamas, Tim Kinnaird, Rasha Al-Lamee, Peter O'Kane, Gerald Clesham, Dan McKenzie, James Nolan, Shrilla Banerjee, Clare Appleby, Adrian Banning, Douglas F Muir, James Spratt, Ellie Gudde, Sarah Carson, Suneil Aggarwal, John Irving, Vinoda Sharma, Ian Purcell, Azfar Zaman, David Hildick-Smith","doi":"10.15420/icr.2024.43","DOIUrl":"10.15420/icr.2024.43","url":null,"abstract":"<p><p>Percutaneous techniques to treat obstructive coronary artery disease continue to evolve and the evidence base informing our practice is shared and summarised in international guidelines. In the UK, the British Cardiovascular Intervention Society represents and supports interventional cardiologists undertaking both coronary and structural interventions. Procedural data are collected in a national registry and these inform our understanding of UK practice and outcomes. These recommendations, pertaining to coronary intervention alone, are an update of those published in 2015 and describe the provision of percutaneous coronary intervention in the UK intended to provide optimal patient care.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"20 ","pages":"e01"},"PeriodicalIF":0.2,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11904421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143626384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Stent Underexpansion and Aorto-ostial Lesions. 支架扩张不足和主动脉-口病变的处理。
IF 0.2 0 PHILOSOPHY Pub Date : 2024-12-23 eCollection Date: 2024-01-01 DOI: 10.15420/icr.2024.10
Luca Paolucci, Asad Shabbir, Marco Lombardi, Adrián Jerónimo, Javier Escaned, Nieves Gonzalo

Stent underexpansion (SU) and aorto-ostial lesions (AOL) are challenging conditions commonly faced during clinical practice in the setting of percutaneous coronary interventions. Compared to other interventional settings, both SU and AOL are associated with an increased risk of immediate and late events following percutaneous coronary intervention. Several specific strategies including the systematic use of intracoronary imaging and dedicated techniques for lesions' preparation and calcium debulking have been described. This narrative review summarises the currently available options for the diagnosis and treatment of both SU and AOL, highlighting the potential benefits and limits of each technique in these specific settings.

在经皮冠状动脉介入治疗的临床实践中,支架扩张不足(SU)和主动脉口病变(AOL)是常见的挑战。与其他介入治疗相比,SU和AOL与经皮冠状动脉介入治疗后即刻和晚期事件的风险增加有关。一些具体的策略,包括系统地使用冠状动脉内成像和专用技术病变的准备和钙减积已经被描述。这篇叙述性综述总结了目前SU和AOL的诊断和治疗方法,强调了每种技术在这些特定情况下的潜在益处和局限性。
{"title":"Management of Stent Underexpansion and Aorto-ostial Lesions.","authors":"Luca Paolucci, Asad Shabbir, Marco Lombardi, Adrián Jerónimo, Javier Escaned, Nieves Gonzalo","doi":"10.15420/icr.2024.10","DOIUrl":"10.15420/icr.2024.10","url":null,"abstract":"<p><p>Stent underexpansion (SU) and aorto-ostial lesions (AOL) are challenging conditions commonly faced during clinical practice in the setting of percutaneous coronary interventions. Compared to other interventional settings, both SU and AOL are associated with an increased risk of immediate and late events following percutaneous coronary intervention. Several specific strategies including the systematic use of intracoronary imaging and dedicated techniques for lesions' preparation and calcium debulking have been described. This narrative review summarises the currently available options for the diagnosis and treatment of both SU and AOL, highlighting the potential benefits and limits of each technique in these specific settings.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"19 ","pages":"e26"},"PeriodicalIF":0.2,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11770534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143053756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management. 急性冠脉综合征冠状动脉扩张:非维生素K拮抗剂口服抗凝剂在治疗中的作用。
IF 0.2 0 PHILOSOPHY Pub Date : 2024-11-27 eCollection Date: 2024-01-01 DOI: 10.15420/icr.2024.25
Mahmoud Izraiq, Nail Alshoubaki, Omran A Abu-Dhaim, Raed Aqel

Coronary artery ectasia (CAE) is an abnormal dilatation of coronary artery segments, often linked with atherosclerosis. This report discusses two cases of CAE presenting as acute coronary syndrome. A 36-year-old man had proximal blockage in the left circumflex artery (LCx) and ectasia in the obtuse marginal artery and left anterior descending artery (LAD), while a 53-year-old male smoker had an ectatic LAD with a substantial thrombus. Both were treated with dual antiplatelet therapy (aspirin and clopidogrel) and non-vitamin K antagonist oral anticoagulants (NOACs), specifically apixaban, along with atorvastatin. The first patient had complete resolution of LCx occlusion after 1 year, and the second patient had complete thrombus dissolution in the LAD in 2 months. These cases highlight the potential benefits of NOACs in managing CAE in acute coronary syndrome, suggesting that triple therapy can significantly improve clinical outcomes.

冠状动脉扩张(CAE)是冠状动脉段的异常扩张,通常与动脉粥样硬化有关。本报告讨论两例CAE表现为急性冠脉综合征。一名36岁男性左旋动脉(LCx)近端阻塞,钝边缘动脉和左前降支(LAD)扩张,而一名53岁男性吸烟者则有扩张的LAD伴大量血栓。两人均接受双重抗血小板治疗(阿司匹林和氯吡格雷)和非维生素K拮抗剂口服抗凝剂(NOACs),特别是阿哌沙班和阿托伐他汀。第1例患者1年后LCx闭塞完全解除,第2例患者2个月LAD内血栓完全溶解。这些病例强调了NOACs治疗急性冠脉综合征CAE的潜在益处,表明三联疗法可以显著改善临床结果。
{"title":"Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management.","authors":"Mahmoud Izraiq, Nail Alshoubaki, Omran A Abu-Dhaim, Raed Aqel","doi":"10.15420/icr.2024.25","DOIUrl":"https://doi.org/10.15420/icr.2024.25","url":null,"abstract":"<p><p>Coronary artery ectasia (CAE) is an abnormal dilatation of coronary artery segments, often linked with atherosclerosis. This report discusses two cases of CAE presenting as acute coronary syndrome. A 36-year-old man had proximal blockage in the left circumflex artery (LCx) and ectasia in the obtuse marginal artery and left anterior descending artery (LAD), while a 53-year-old male smoker had an ectatic LAD with a substantial thrombus. Both were treated with dual antiplatelet therapy (aspirin and clopidogrel) and non-vitamin K antagonist oral anticoagulants (NOACs), specifically apixaban, along with atorvastatin. The first patient had complete resolution of LCx occlusion after 1 year, and the second patient had complete thrombus dissolution in the LAD in 2 months. These cases highlight the potential benefits of NOACs in managing CAE in acute coronary syndrome, suggesting that triple therapy can significantly improve clinical outcomes.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"19 ","pages":"e25"},"PeriodicalIF":0.2,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wire Escalation And De-escalation Techniques in Antegrade and Retrograde Approaches to Chronic Total Occlusion Percutaneous Coronary Interventions. 慢性全闭塞经皮冠状动脉介入治疗的顺、逆行入路中的钢丝升高和降低技术。
IF 0.2 0 PHILOSOPHY Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.15420/icr.2024.14
Laura Novelli, Jorge Sanz-Sanchez, Gabriele Gasparini

Coronary chronic total occlusions (CTO) are frequently identified during coronary angiography and remain the most challenging subset of coronary artery lesions to treat; however, advancements in techniques and materials have greatly improved success rates. Various crossing algorithms have been developed to standardise the approach to CTO interventions based on angiographic criteria. Antegrade wiring is typically the initial strategy of choice, particularly in cases of short and straight CTOs with tapered proximal cap. Similarly, retrograde crossing can be achieved through retrograde wiring, although this approach has a very low success rate. This review aims to outline how to perform a CTO analysis, clarify the fundamental features of guidewires and provide insights into both antegrade and retrograde wire-based approaches.

冠状动脉慢性全闭塞(CTO)经常在冠状动脉造影中被发现,并且仍然是冠状动脉病变中最具挑战性的治疗亚群;然而,技术和材料的进步大大提高了成功率。各种交叉算法已经开发标准化的方法,以血管造影标准为基础的CTO干预。顺行布线通常是首选的初始策略,特别是在近端帽变细的短而直的cto的情况下。同样,逆行布线可以实现逆行交叉,尽管这种方法成功率非常低。本文旨在概述如何进行CTO分析,阐明导丝的基本特征,并对顺行和逆行导丝方法提供见解。
{"title":"Wire Escalation And De-escalation Techniques in Antegrade and Retrograde Approaches to Chronic Total Occlusion Percutaneous Coronary Interventions.","authors":"Laura Novelli, Jorge Sanz-Sanchez, Gabriele Gasparini","doi":"10.15420/icr.2024.14","DOIUrl":"10.15420/icr.2024.14","url":null,"abstract":"<p><p>Coronary chronic total occlusions (CTO) are frequently identified during coronary angiography and remain the most challenging subset of coronary artery lesions to treat; however, advancements in techniques and materials have greatly improved success rates. Various crossing algorithms have been developed to standardise the approach to CTO interventions based on angiographic criteria. Antegrade wiring is typically the initial strategy of choice, particularly in cases of short and straight CTOs with tapered proximal cap. Similarly, retrograde crossing can be achieved through retrograde wiring, although this approach has a very low success rate. This review aims to outline how to perform a CTO analysis, clarify the fundamental features of guidewires and provide insights into both antegrade and retrograde wire-based approaches.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"19 ","pages":"e23"},"PeriodicalIF":0.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11622219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
British Cardiovascular Intervention Society Training Culture Focus Group Position Statement: Bringing Trainees and Trainers Together. 英国心血管介入学会培训文化焦点小组立场声明:让受训者和培训师走到一起。
IF 0.2 0 PHILOSOPHY Pub Date : 2024-11-04 eCollection Date: 2024-01-01 DOI: 10.15420/icr.2024.07
Thomas R Gilpin, Holly Morgan, Christian Fielder Camm, Alexandra Moss, James Cotton, Raghav T Bhatia, Dan McKenzie, Rasha Al-Lamee, Simon Ray, Nick Curzen

Unprofessional behaviour within cardiology has been well documented and commonly occurs within the cardiac catheterisation laboratory, with higher rates in interventional subspecialities. While most trainees have positive experiences and encounters within the catheterisation laboratory, around one in five report experiencing bullying. This not only has a significant negative impact on the individuals directly involved, but also on the wider multidisciplinary team; importantly, it will have a deleterious effect on patient safety. The British Cardiovascular Intervention Society established the Training Culture Focus Group in 2022 to analyse and offer potential solutions to this pressing issue. We recommend that a cohesive approach between trainers and trainees is the most effective way to reduce unprofessional behaviour incidents, thus improving departmental workplace culture and a subsequent reduction in adverse patient safety events.

心脏病学中的不专业行为已被充分记录在案,通常发生在心导管室,介入亚专科的发生率更高。虽然大多数受训人员在导管室都有积极的经历和遭遇,但约有五分之一的受训人员表示曾遭受过欺凌。这不仅会对直接相关的个人产生严重的负面影响,还会影响到更广泛的多学科团队;更重要的是,它会对患者安全产生有害影响。英国心血管介入学会于 2022 年成立了培训文化焦点小组,以分析这一紧迫问题并提供潜在的解决方案。我们建议,培训师和受训人员之间采取协调一致的方法是减少非专业行为事件的最有效途径,从而改善科室工作场所文化,进而减少不良患者安全事件。
{"title":"British Cardiovascular Intervention Society Training Culture Focus Group Position Statement: Bringing Trainees and Trainers Together.","authors":"Thomas R Gilpin, Holly Morgan, Christian Fielder Camm, Alexandra Moss, James Cotton, Raghav T Bhatia, Dan McKenzie, Rasha Al-Lamee, Simon Ray, Nick Curzen","doi":"10.15420/icr.2024.07","DOIUrl":"10.15420/icr.2024.07","url":null,"abstract":"<p><p>Unprofessional behaviour within cardiology has been well documented and commonly occurs within the cardiac catheterisation laboratory, with higher rates in interventional subspecialities. While most trainees have positive experiences and encounters within the catheterisation laboratory, around one in five report experiencing bullying. This not only has a significant negative impact on the individuals directly involved, but also on the wider multidisciplinary team; importantly, it will have a deleterious effect on patient safety. The British Cardiovascular Intervention Society established the Training Culture Focus Group in 2022 to analyse and offer potential solutions to this pressing issue. We recommend that a cohesive approach between trainers and trainees is the most effective way to reduce unprofessional behaviour incidents, thus improving departmental workplace culture and a subsequent reduction in adverse patient safety events.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"19 ","pages":"e22"},"PeriodicalIF":0.2,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atherectomy Techniques: Rotablation, Orbital and Laser. 动脉粥样硬化切除术:旋转、轨道和激光。
IF 0.2 0 PHILOSOPHY Pub Date : 2024-10-31 eCollection Date: 2024-01-01 DOI: 10.15420/icr.2024.16
Sophia Khattak, Harish Sharma, Sohail Q Khan

Coronary artery disease remains the leading cause of morbidity and mortality worldwide despite advancements in percutaneous coronary intervention (PCI). With an increasing ageing population, there is a significant challenge in addressing severe calcification in atherosclerotic plaque during angioplasty. This review article focuses on atherectomy strategies such as rotational atherectomy (RA), orbital atherectomy (OA) and excimer laser coronary angioplasty (ELCA) aimed at modifying calcified lesions and improving PCI outcomes. RA modifies plaque through rotational ablation, OA uses eccentrically mounted diamond-coated crown and has a reduced entrapment risk compared to RA. ELCA uses pulsatile laser energy to precisely ablate plaque tissue. This review provides insights into the mechanisms, procedural techniques and clinical outcomes associated with these calcium modification techniques. The selection of appropriate devices and adequate training are crucial for optimising lesion modification and enhancing procedural success. Further research and standardised protocols are required to overcome challenges associated with using these devices and expand their usage in clinical practice.

尽管经皮冠状动脉介入治疗(PCI)技术不断进步,冠状动脉疾病仍然是全球发病率和死亡率的主要原因。随着人口老龄化的加剧,在血管成形术中处理动脉粥样硬化斑块中的严重钙化是一项重大挑战。这篇综述文章重点介绍了旨在改变钙化病变并改善 PCI 治疗效果的动脉粥样硬化切除术(RA)、轨道动脉粥样硬化切除术(OA)和准分子激光冠状动脉成形术(ELCA)等策略。RA 通过旋转消融来改变斑块,OA 使用偏心安装的钻石涂层冠,与 RA 相比可降低夹层风险。ELCA 使用脉冲激光能量精确消融斑块组织。本综述深入探讨了这些钙修饰技术的相关机制、程序技术和临床结果。选择合适的设备和充分的培训对于优化病变修饰和提高手术成功率至关重要。要克服与使用这些设备相关的挑战并扩大其在临床实践中的应用,还需要进一步的研究和标准化方案。
{"title":"Atherectomy Techniques: Rotablation, Orbital and Laser.","authors":"Sophia Khattak, Harish Sharma, Sohail Q Khan","doi":"10.15420/icr.2024.16","DOIUrl":"10.15420/icr.2024.16","url":null,"abstract":"<p><p>Coronary artery disease remains the leading cause of morbidity and mortality worldwide despite advancements in percutaneous coronary intervention (PCI). With an increasing ageing population, there is a significant challenge in addressing severe calcification in atherosclerotic plaque during angioplasty. This review article focuses on atherectomy strategies such as rotational atherectomy (RA), orbital atherectomy (OA) and excimer laser coronary angioplasty (ELCA) aimed at modifying calcified lesions and improving PCI outcomes. RA modifies plaque through rotational ablation, OA uses eccentrically mounted diamond-coated crown and has a reduced entrapment risk compared to RA. ELCA uses pulsatile laser energy to precisely ablate plaque tissue. This review provides insights into the mechanisms, procedural techniques and clinical outcomes associated with these calcium modification techniques. The selection of appropriate devices and adequate training are crucial for optimising lesion modification and enhancing procedural success. Further research and standardised protocols are required to overcome challenges associated with using these devices and expand their usage in clinical practice.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"19 ","pages":"e21"},"PeriodicalIF":0.2,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interventional Cardiology Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1